Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1995 Oct;59(4):381–383. doi: 10.1136/jnnp.59.4.381

Raised plasma arginine vasopressin concentrations during cluster headache attacks.

R Franceschini 1, M Leandri 1, A Cataldi 1, E Bruno 1, G Corsini 1, E Rolandi 1, T Barreca 1
PMCID: PMC486073  PMID: 7561916

Abstract

To obtain data about peripheral concentrations of arginine vasopressin in head pain syndromes, the plasma arginine vasopressin secretory pattern in 12 adult male patients with cluster headache was evaluated. Blood samples for plasma arginine vasopressin and osmolality determinations were collected before, and at 15, 30, 45, 60, 90, and 120 minutes during a cluster attack. Blood pressure was also monitored. The same sampling was repeated during an asymptomatic period. During cluster attacks, the mean values of plasma arginine vasopressin before an attack (2.3 (0.1) ng/l) significantly increased, reaching their peak at 45 minutes (4.8 (0.5) ng/l; P < 0.01 v baseline). No significant variations were found in mean arterial pressure and plasma osmolality. These data suggested involvement of neurotransmitter mechanisms regulating arginine vasopressin secretion and a possible role of arginine vasopressin in vasomotor phenomena accompanying cluster attacks.

Full text

PDF
381

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cunningham E. T., Jr, Sawchenko P. E. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol. 1988 Aug 1;274(1):60–76. doi: 10.1002/cne.902740107. [DOI] [PubMed] [Google Scholar]
  2. Day T. A., Sibbald J. R. Noxious somatic stimuli excite neurosecretory vasopressin cells via A1 cell group. Am J Physiol. 1990 Jun;258(6 Pt 2):R1516–R1520. doi: 10.1152/ajpregu.1990.258.6.R1516. [DOI] [PubMed] [Google Scholar]
  3. Hampton K. K., Esack A., Peatfield R. C., Grant P. J. Elevation of plasma vasopressin in spontaneous migraine. Cephalalgia. 1991 Dec;11(6):249–250. doi: 10.1046/j.1468-2982.1991.1106249.x. [DOI] [PubMed] [Google Scholar]
  4. Husain M. K., Manger W. M., Rock T. W., Weiss R. J., Frantz A. G. Vasopressin release due to manual restraint in the rat: role of body compression and comparison with other stressful stimuli. Endocrinology. 1979 Mar;104(3):641–644. doi: 10.1210/endo-104-3-641. [DOI] [PubMed] [Google Scholar]
  5. Kendler K. S., Weitzman R. E., Fisher D. A. The effect of pain on plasma arginine vasopressin concentrations in man. Clin Endocrinol (Oxf) 1978 Feb;8(2):89–94. doi: 10.1111/j.1365-2265.1978.tb02156.x. [DOI] [PubMed] [Google Scholar]
  6. Leone M., Bussone G. A review of hormonal findings in cluster headache. Evidence for hypothalamic involvement. Cephalalgia. 1993 Oct;13(5):309–317. doi: 10.1046/j.1468-2982.1993.1305309.x. [DOI] [PubMed] [Google Scholar]
  7. Leone M., Patruno G., Vescovi A., Bussone G. Neuroendocrine dysfunction in cluster headache. Cephalalgia. 1990 Oct;10(5):235–239. doi: 10.1046/j.1468-2982.1990.1005235.x. [DOI] [PubMed] [Google Scholar]
  8. Lightman S. L., Forsling M. Evidence for dopamine as an inhibitor of vasoprotein release in man. Clin Endocrinol (Oxf) 1980 Jan;12(1):39–46. doi: 10.1111/j.1365-2265.1980.tb03130.x. [DOI] [PubMed] [Google Scholar]
  9. Mohr E., Richter D. Vasopressin in the regulation of body functions. J Hypertens. 1994 Apr;12(4):345–348. [PubMed] [Google Scholar]
  10. Nussey S. S., Hawthorn J., Page S. R., Ang V. T., Jenkins J. S. Responses of plasma oxytocin and arginine vasopressin to nausea induced by apomorphine and ipecacuanha. Clin Endocrinol (Oxf) 1988 Mar;28(3):297–304. doi: 10.1111/j.1365-2265.1988.tb01216.x. [DOI] [PubMed] [Google Scholar]
  11. Peatfield R. C., Hampton K. K., Grant P. J. Plasma vasopressin levels in induced migraine attacks. Cephalalgia. 1988 Mar;8(1):55–57. doi: 10.1046/j.1468-2982.1988.0801055.x. [DOI] [PubMed] [Google Scholar]
  12. Poole C. J., Lightman S. L. Inhibition of vasopressin secretion during migraine. J Neurol Neurosurg Psychiatry. 1988 Nov;51(11):1441–1444. doi: 10.1136/jnnp.51.11.1441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Resink T. J., Erne P., Bühler F. R. The influence of CGP 28392, a 1,4-dihydropyridine, on human platelet calcium and cyclic AMP metabolism. Eur J Pharmacol. 1985 Jul 31;113(3):383–393. doi: 10.1016/0014-2999(85)90086-x. [DOI] [PubMed] [Google Scholar]
  14. Robertson G. L. The regulation of vasopressin function in health and disease. Recent Prog Horm Res. 1976;33:333–385. doi: 10.1016/b978-0-12-571133-3.50015-5. [DOI] [PubMed] [Google Scholar]
  15. Veltmar A., Culman J., Qadri F., Rascher W., Unger T. Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release. J Pharmacol Exp Ther. 1992 Dec;263(3):1253–1260. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES